VikramsinhM.DabhiMD

Physician

Dr. Dabhi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

University of WashingtonFellowship, Hematology and Medical Oncology, 2002 - 2005
Emory University School of MedicineResidency, Internal Medicine, 1998 - 2001
University of Texas Southwestern Medical SchoolClass of 1998

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

Short peptides sensitize target cells to CTL specific for the MHC class Ib molecule, H2-M3.
Dabhi, V. M., Lindahl, K. F.> ;Eur J Immunol. 1998 Nov
The alloreactive T cell response against the class Ib molecule H2-M3 is specific for high affinity peptides.
Dabhi, V. M., Hovik, R., Van Kaer, L., Lindahl, K. F.> ;J Immunol. 1998 Nov 15
H2-M3, a full-service class Ib histocompatibility antigen.
Lindahl, K. F., Byers, D. E., Dabhi, V. M., Hovik, R., Jones, E. P., Smith, G. P., Wang, C. R., Xiao, H., Yoshino, M.> ;Annu Rev Immunol. 1997
CTL respond to a mitochondrial antigen presented by H2-Db.
Dabhi, V. M., Lindahl, K. F.> ;Immunogenetics. 1996
The COI mitochondrial gene encodes a minor histocompatibility antigen presented by H2-M3.
Morse, M. C., Bleau, G., Dabhi, V. M., Hétu, F., Drobetsky, E. A., Lindahl, K. F., Perreault, C.> ;J Immunol. 1996 May 1
MtDNA-encoded histocompatibility antigens.
Dabhi, V. M., Lindahl, K. F.> ;Methods Enzymol. 1995
Presentation of N-formylated peptides by H2-M3.
Lindahl, K. F., Dabhi, V. M., Hovik, R., Smith, G. P., Wang, C. R.> ;Biochem Soc Trans. 1995 Aug
Peptide presentation by the MHC class Ib molecule, H2-M3.
Smith, G. P., Dabhi, V. M., Pamer, E. G., Lindahl, K. F.> ;Int Immunol. 1994 Dec
Join now to see all